Headache & Migraine

Add Content

• Definition
• Introduction
• Signs & Symptoms
• Research Summary

Presentation Slides

---

Executive Summary

---

Write an executive summary in the form of a blog article on the topic of "Research into Chinese medicine treatment for Headache & Migraine" summarising the research below and using language that can be easily understood by patients and avoiding medical jargon using a professional and caring tone of voice.

Write an executive summary in the form of a blog article on the topic of "Researched Chinese medicine treatments for Headache & Migraine" summarising the research below in an objective and easy to understand way, and using language that can be easily understood by patients. Group the article into Chinese medicine treatments first, followed by nutrition and other treatments. Avoid using medical jargon and use a professional and caring tone of voice.

Write me a concise but easy to understand executive summary on the topic of "Chinese medicine treatments for Headache & Migraine" based on the following research that I will give you. Your summary should be 2 paragraphs long in Australian English spelling and include references to the studies.

A Review Article published in 2022 in the journal Expert Review of Neurotherapeutics found that A 6-week course of acupuncture proves as effective as 6-month drug prophylaxis for migraines, with specific Chinese point selection and stimulation appearing less important. The study began by revisiting previous research on acupuncture as a treatment for headache, finding shortcomings in many of these studies. It explored the influence of acupuncture on migraine and how it potentially functions. The methodology involved running several large, randomized trials comparing the use of acupuncture to conventional prophylactic drug treatments, spanning a time frame of six weeks to six months, respectively. In the discussion of the results, it was found that the 6-week acupuncture treatment was just as effective in treating migraines as the 6-month drug treatment. Specific attributes of the acupuncture treatment, such as the selection and stimulation of Chinese points and the depth of the needles, were found to have lower significance than traditionally believed. The paper therefore suggested the integration of acupuncture into existing migraine therapy protocols.

A Randomised Controlled Trial published in 2022 in the journal Neurology found that True acupuncture over an eight-week period is effective for reducing the frequency of chronic tension-type headache. In a randomized controlled trial, 218 participants diagnosed with chronic tension-type headache were divided into an intervention group and a control group, with the study conducted from June 2017 to September 2020. The intervention group received 20 true acupuncture sessions over 8 weeks, where each acupuncture point was needled to achieve a sensation, each session lasting 30 minutes. The control group received the same number of superficial acupuncture sessions, serving as a make-believe treatment, where the needling avoided inducing sensations at the acupuncture points. The results showed a trend towards greater effectiveness of true acupuncture. By week 16, the 'responder rate' (participants reporting at least a 50% reduction in monthly headache days) was higher in the true acupuncture group compared to the superficial acupuncture group, with similar results by week 32. These findings suggest that true acupuncture, involving the creation of a sensation at each acupuncture site, can noticeably reduce chronic tension-type headaches. This was observed without noting significant adverse events, hinting towards the safety of the procedure.

A Randomised Controlled Trial published in 2021 in the journal Frontiers in Neurology found that Acupuncture could be as effective as pharmacological drugs for migraine prevention, with improved patient compliance and fewer adverse events. In the study, patients experiencing migraines who hadn't undergone preventive treatment in the prior 3 months were randomly divided into two groups. Group A underwent 12 acupuncture sessions, while Group B received a range of suitable medications for each individual. The frequency of headaches was compared at the beginning and end of treatment, and both groups were assessed after three and six months post-treatment. Results highlighted that both treatments led to a significant decrease in headache frequency. Of the patients, around 34% saw a 50% reduction of headache days post-treatment. The improvements seen at the end of treatment were maintained in 57.3% of patients three months after and in 38.8% of patients six months after, notably in the acupuncture group. Based on this data, acupuncture can be seen as an effective alternative for migraine prophylaxis.

A Systematic Review published in 2020 in the journal Neurology and Therapy found that In many studies, acupuncture has been shown to be a safe, efficacious and readily available alternative therapy which may be beneficial to certain migraine patients. Migraines are difficult to treat, and current treatment options have many unwanted side effects, such as exacerbating headache pain in those with chronic migraine. Therefore, while the primary treatment for migraines is drug therapy, acupuncture is gaining increasing attention as a viable addition to the treatment management of migraine patients due to its measurable effects on both the duration and frequency of migraine attacks. Many studies suggest that acupuncture is a safe, helpful and available alternative therapy that may be beneficial to certain migraine patients. Nevertheless, further large-scale RCTs are warranted to further consolidate these findings and provide further support for the clinical value of acupuncture.

A Systematic Review published in 2020 in the journal Pain Research & Management found that Acupuncture reduced more headache days and the times of using painkiller and was more effective in reducing the frequency and degree of headache than western medicine and sham acupuncture. Based on high quality of evidence, we conclude that acupuncture is more effective and safer than medication or sham acupuncture in the treatment of migraine. However, the methodological quality, risk of bias, and reporting quality of SRs in acupuncture for migraine still needs improvement in future.

A Systematic Review published in 2019 in the journal Headache found that There is growing evidence that acupuncture is just as effective and has fewer side effects than many of the standard pharmaceutical agents that are currently used. Out of the 706 search results, 7 clinical trials, with a total of 1430 participants, met inclusion criteria for trials comparing the effectiveness of acupuncture to standard pharmacologic treatment. Several of the studies showed acupuncture to be more effective than standard pharmacological treatments for migraine prevention; however, methodological heterogeneity precluded aggregation of these data.

A Systematic Review published in 2019 in the journal Pain Research & Management found that Acupuncture has the advantage for acute and preventive treatment of migraine in pain improvement and safety. This overview included a considerable number of systematic reviews/meta analyses (SR/MAs), illustrating that acupuncture has the advantage in pain improvement of VAS score, headache days/frequency, analgesic use and efficacy of response rate, and effective rate according to the present evidence. In terms of conclusion, the results of all 15 (100%) SR/MAs were positive. For treatment, 6 SR/MAs reported acupuncture had superiority relative to drugs; 4 SR/MAs reported acupuncture had superiority relative to sham acupuncture, drugs; 3 SR/MAs reported acupuncture had superiority relative to sham acupuncture; 1 SR/MA reported acupuncture had superiority relative to drugs, other TCM treatments. 1 SR/MA reported that acupuncture had superiority in treating migraine, but did not mention the control group in the conclusions. Based on previous evidence we reviewed, we supposed acupuncture might be a kind of available treatment for migraine in preventive or acute treatment, but in consideration of low methodological quality of present SR/MAs or RCTs of acupuncture for migraine, we need more high-quality evidence to demonstrate the effect of acupuncture for migraine.

A Review Article published in 2019 in the journal Neuropediatrics found that Currently, acupuncture is considered to be a safe, helpful, and available alternative option for patients who have not responded to or complied with conventional pharmacotherapy. The authors conducted an exhaustive review of existing literature exploring the use of acupuncture to address migraine headaches in children. This review encompassed understanding the neurobiological mechanisms of acupuncture, studies on adult headaches, pediatric headache studies, consideration of acupuncture's safety, and its application in other health conditions present in children. The findings of this review suggested that acupuncture emerges as a safe and effective treatment option for migraine in children. Evidence proposes that it can be effectively integrated into the primary treatment regime to reduce the child's discomfort and pain. The effectiveness of acupuncture comes with the added advantage of being safe, with negligible risks, especially important when dealing with young patients. These insights support acupuncture to be seriously considered as an auxiliary treatment strategy for migraines in children.

A Systematic Review published in 2019 in the journal World Journal of Acupuncture-Moxibustion found that The results of this meta-analysis showed that acupuncture is more effective and safer than medication for migraine. A total of 13 trails including 1218 participants met the selection criteria. The meta-analysis of 3 articles showed that acupuncture was more effective in reducing the frequency of migraine attacks than medication. The meta-analysis of three articles showed that acupuncture was more effective in reducing the number of migraine days than medication after treatment. The meta-analysis of six articles showed that acupuncture was more effective in reducing VAS after treatment. The meta-analysis of two articles showed that acupuncture was more effective in reducing VAS during follow-up. The meta-analysis of seven articles showed that the total effective rate of acupuncture was higher than that of medication. In addition, fewer adverse effects in acupuncture groups were reported than in medication groups. Overall the quality of the evidence was low. The results of this meta-analysis showed that acupuncture is more effective and safer than medication for migraine. Acupuncture can be considered a treatment option for patients willing to undergo this treatment. But more high-quality studies, based on standardized, comprehensive and objective evaluation, are required to enhance the reliability of the conclusion.

A Systematic Review published in 2017 in the journal The Journal of Pain found that Acupuncture has a clinically relevant effect on chronic pain that persists over time. Referral for acupuncture treatment is a reasonable option for chronic pain patients. We included randomized trials of acupuncture needling versus either sham acupuncture or no acupuncture control for nonspecific musculoskeletal pain, osteoarthritis, chronic headache, or shoulder pain. Trials were only included if allocation concealment was unambiguously determined to be adequate. Raw data were obtained from study authors and entered into an individual patient data meta-analysis. The main outcome measures were pain and function. An additional 13 trials were identified, with data received for a total of 20,827 patients from 39 trials. Acupuncture was superior to sham as well as no acupuncture control for each pain condition (all P < .001) with differences between groups close to .5 SDs compared with no acupuncture control and close to .2 SDs compared with sham. We also found clear evidence that the effects of acupuncture persist over time with only a small decrease, approximately 15%, in treatment effect at 1 year. Acupuncture is effective for the treatment of chronic musculoskeletal, headache, and osteoarthritis pain. Treatment effects of acupuncture persist over time and cannot be explained solely in terms of placebo effects. Referral for a course of acupuncture treatment is a reasonable option for a patient with chronic pain.

A Randomised Controlled Trial published in 2016 in the journal Neural Regeneration Research found that A 14-session course of needling at Fengchi is relatively safe for treating posterior circulation ischemia with vertigo. Acupuncture at Fengchi (GB20) in the posterior neck improves vertigo. However, subarachnoid hemorrhage and spinal epidural hematoma have been reported to occur after acupuncture in the posterior neck. Therefore, in the present study, we assessed the safety of acupuncture at Fengchi. Of the 136 patients, 120 completed the study. There were no significant differences between pretreatment and posttreatment test results in any of the groups. Only five patients suffered from minor adverse events (needling pain, slight hematoma and transient chest tightness). No serious adverse events were found. Our results indicate that a 14-session course of needling at Fengchi is relatively safe for treating posterior circulation ischemia with vertigo.

A Systematic Review published in 2016 in the journal Cochrane Database of Systematic Reviews found that The available evidence suggests that adding acupuncture to symptomatic treatment of attacks reduces the frequency of headaches. Contrary to the previous findings, the updated evidence also suggests that there is an effect over sham, but this effect is small. The available trials also suggest that acupuncture may be at least similarly effective as treatment with prophylactic drugs. Acupuncture can be considered a treatment option for patients willing to undergo this treatment.

A Systematic Review published in 2016 in the journal Cochrane Database of Systematic Reviews found that The available evidence suggests that a course of acupuncture consisting of at least six treatment sessions can be a valuable option for people with frequent tension-type headache. Acupuncture added to usual care or treatment of headaches only on onset (usually with pain-killers) in two large trials resulted in 48 in 100 participants having headache frequency at least halved, compared to 17 of 100 participants given usual care only. Acupuncture was compared with ‘fake’ acupuncture, where needles are inserted at incorrect points or do not penetrate the skin, in six trials. Headache frequency halved in 52 of 100 participants receiving true acupuncture compared with 43 of 100 participants receiving ‘fake’ acupuncture. The results were dominated by one large, good quality trial (with about 400 participants), which showed that the effect of true acupuncture was still present after six months. There were no differences in the number of side effects of real and ‘fake’ acupuncture, or the numbers dropping out because of side effects.

A Clinical Study published in 2015 in the journal BMC Complementary Medicine and Therapies found that Acupuncture demonstrates a significant immediate effect in reducing discomforts and VAS of both dizziness and vertigo. Acupuncture demonstrates a significant immediate effect in reducing discomforts and VAS of both dizziness and vertigo. This study provides clinical evidence on the efficacy and safety of acupuncture to treat dizziness and vertigo in the emergency department.

A Systematic Review published in 2001 in the journal Cochrane Database of Systematic Reviews found that The existing evidence supports the value of acupuncture for the treatment of idiopathic headaches. Due to the clinical heterogeneity and the poor methodological quality of the included studies, straightforward recommendations for clinical practice cannot be made. Overall, some forms of acupuncture seem to be beneficial, but it is unclear which treatment strategies (points, type of stimulation, frequency, etc.) and which providers may be most promising for particular groups of patients. Though not risk‐free, acupuncture seems to be relatively safe in the hands of qualified providers. Therefore, we conclude that headache patients who want to try acupuncture should not be discouraged. Existing provision of acupuncture to headache patients also seems justified. Whether acupuncture should be more widely recommended and, if so, which particular type of acupuncture should be offered, are questions that cannot be answered at present.

A Clinical Study published in 2000 in the journal Clinica Chimica Acta found that Migraine patients exhibit lower intracellular magnesium levels, which can be increased by consuming magnesium-rich mineral water, demonstrating its bioavailability. The study started by identifying a common issue with lower-than-recommended dietary intakes of magnesium in Western countries. The focus was on migraine patients, as low brain magnesium and impaired magnesium metabolism had been reported in migraine cases. A non-invasive and sensitive test to detect these deficiencies was sought. Magnesium, being an intracellular cation, was tested in 29 migraine patients and 18 control subjects. The tests were for total magnesium in plasma, erythrocytes, lymphocytes and ionized magnesium in lymphocytes. The analysis found that there were lower concentrations of total magnesium in erythrocytes and ionized magnesium in lymphocytes of migraine patients compared to controls. These findings indicated a notable overall difference between the migraine patients and the controls, despite there being overlaps in some individual values. The researchers then subjected the migraine patients to a 2-week intake of a mineral water rich in magnesium. An increase in all intracellular magnesium concentrations was observed, with no effect on plasma magnesium. This increase demonstrated the bioavailability of magnesium from the mineral water. Interestingly, the most sensitive index of magnesium deficiency turned out to be ionized magnesium in lymphocytes, which saw the most significant increase after the intake of the magnesium-rich mineral water.

Moderation Tools

---

Topic